Human monoclonal antibodies against orexin receptor type 1

The present invention relates to human monoclonal antibodies against orexin receptor type 1 (OX1R) and uses thereof for the treatment of cancer.

Keywords: pancreas, colon, liver, prostate
Patent Application number: European Procedure (Patents) (EPA) - 16 Janv. 2015 - 15 305 038.0
Inventors:
MARTINEAU Pierre,ROBERT Bruno,CHENTOUF Myriam,VOISIN Thierry,NICOLE Pascal

Reference:

BIO14361-T1

Business Developper
contact
Aymeric Empereur
Business Developer
Patent filling date: 16-01-2015
Rare disease: No
Second indication: No

You might also be interested in